Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Jacobson Mark L.
Chief Operating Officer at Axsome Therapeutics. Filing since 1 Apr 2024.
CIK 0001805812
Company
Date
Role
Action
Shares
Amount
Of holding
AXSM
Axsome Therapeutics, Inc.
3 Sep 2026
Chief Operating Officer
Sold on a plan
10,000
$2.09M
100%
AXSM
Axsome Therapeutics, Inc.
5 May 2026
Chief Operating Officer
Sold on a plan
233
$53.17K
100%
AXSM
Axsome Therapeutics, Inc.
4 May 2026
Chief Operating Officer
Sold on a plan
4,517
$1.03M
100%
AXSM
Axsome Therapeutics, Inc.
26 Feb 2026
Chief Operating Officer
Sold on a plan
35,378
$5.73M
100%
AXSM
Axsome Therapeutics, Inc.
22 Sep 2025
Chief Operating Officer
Sold on a plan
10,000
$1.16M
100%
AXSM
Axsome Therapeutics, Inc.
16 Sep 2025
Chief Operating Officer
Sold on a plan
45,783
$5.24M
100%
AXSM
Axsome Therapeutics, Inc.
9 Jun 2025
Chief Operating Officer
Sold on a plan
25,000
$2.76M
81.2%
AXSM
Axsome Therapeutics, Inc.
28 May 2025
Chief Operating Officer
Sold on a plan
20,000
$2.07M
77.6%
AXSM
Axsome Therapeutics, Inc.
27 May 2025
Chief Operating Officer
Sold on a plan
20,673
$2.16M
78.1%
AXSM
Axsome Therapeutics, Inc.
9 Aug 2024
Chief Operating Officer
Sold on a plan
47,739
$4.02M
89.2%
AXSM
Axsome Therapeutics, Inc.
29 May 2024
Chief Operating Officer
Sold at will
7,910
$587.81K
57.8%
AXSM
Axsome Therapeutics, Inc.
1 Apr 2024
Chief Operating Officer
Sold on a plan
24,662
$1.90M
100%
12 decisions on file.
